Dexcom has issued a Class I recall for its G6 Android app due to crashes that could cause users to miss critical glucose ...

Dexcom’s “Smart Basal” has received FDA clearance for people with type 2 diabetes using long-acting insulin. The feature will ...

Shares have lagged the market this year, partly due to some public image and regulatory issues. DexCom's stock could drop even more if results falls short of revenue expectations. Whatever happens on ...

What if your surveillance system could do more than just watch? Imagine cameras so advanced they not only capture every detail in stunning 4K resolution but also intelligently analyze their ...

Dexcom recalled an Android app for its G6 glucose sensor due to a software problem that could cause the app to terminate unexpectedly. The issue could cause users to miss alarms, alerts or ...

The company’s technology utilizes data from various sensors to monitor critical assets, aiming to minimize downtime and reduce maintenance costs. With a current market capitalization of $46.7 million ...

The CGM market is expected to experience double-digit percentage growth over the next five years, reaching nearly $29 billion ...

Patients with type 2 diabetes demonstrated improved glycemic control with the use of automated insulin delivery regardless of baseline C-peptide levels. Automated insulin delivery (AID) systems should ...

Abstract: Pedestrian Dead Reckoning (PDR) is a widely used indoor localization technique that does not require infrastructure and can exploit smartphone inertial sensors. However, it suffers from ...

Abstract: Sensors and actuators placements play an important role in the control performance of an active vibration control system for piezoelectric smart aero-engine blades. Incorrect placement of ...